Clinical efficacy of peritoneovenous shunting for the treatment of severe ovarian hyperstimulation syndrome

Human Reproduction

Volumn 15, Issue 1, 2000, Pages 113-117

  Koike, Toshimitsu ^a   Araki, Shigeo ^a   Minakami, Hisanori ^a   Ogawa, Shuichi ^a   Sayama, Masaaki ^a   Shibahara, Hiroaki ^a   Sato, Ikuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Albumin; Assisted reproductive technologies; Ovarian hyperstimulation syndrome; Peritoneovenous shunt

Indexed keywords

DIURETIC AGENT; FUROSEMIDE; HUMAN ALBUMIN; MANNITOL; PROTEIN;

ADULT; ARTICLE; ASCITES; BLOOD CLOTTING; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FIBRINOLYSIS; HEMATOCRIT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; OVARY DISEASE; PERITONEUM VEIN SHUNT; PLASMA VOLUME; PROTEIN BLOOD LEVEL; PULSE PRESSURE; TIME; TREATMENT OUTCOME; URINE VOLUME;

EID: 0033982595     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.1.113     Document Type: Article

References (36)

1. Aboulghar, M.A., Mansour, R.T., Serour, G.I. et al. (1990) Ultrasonically guided vaginal aspiration of ascites in the treatment of severe ovarian hyperstimulation syndrome. Fenil. Steril., 53, 933-935.
2. Aboulghar, M.A., Riad, R., Mansour, R.T. et al. (1992) Autotransfusion of the ascitic fluid in the treatment of severe ovarian hyperstimulation syndrome. Fertil. Steril., 58, 1056-1059.
3. Anand, A., Gray, E.S., Brown, T. et al. (1987) Human parvovirus infection in pregnancy and hydrops fetalis. N. Engl. J. /(ted., 316, 183-186.
4. Arroyo, V., Gines, P., Planas, R. et al. (1988) Paracentesis in the management of cirrhotics with ascites. In Epstein, M. (ed.), The Kidney in Liver Disease, 3rd edn. Williams & Wilkins, Baltimore, 578 pp.
5. Balasch, J., Fabregues, F., Arroyo, V. et al. (1996) Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach. Acta Obstet. Gynecol. Scand, 75, 662-667.
6. Beck, D.H., Massey, S., Taylor, B.L. et al. (1995) Continuous ascitic recirculation in severe ovarian hyperstimulation syndrome. Intensive Care Med., 21, 590-593.
7. Bithell, T.C. (1993) Blood coagulation. In Richard Lee, G., Bithell, T.C., Foerster, J. et al. (eds), Wintrobe's Clinical Hematology, 9th edn. Lea & Febiger, Philadelphia, 566 pp.
8. Borenstein, R., Elhalah, U., Lunenfeld, B. et al. (1989) Severe ovarian hyperstimulation syndrome: a revaluated therapeutic approach. Fertil. Steril., 51, 791-795.
9. Brinsden, P.I., Wada, I., Tan, S.L. et al. (1995) Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br. J. Obstet. Gynaecol.,102, 767-772.
10. Brown, T., Anand, A., Ritchie, L.D. et al. (1984) Intrauterine parvovirus infection associated with hydrops fetalis. Lancet, ii, 1033-1034.
11. Bruno, S., Borzio, M., Romagnoni, M. et al. (1992) Comparison of spontaneous ascites filtration and reinfusion with total paracentesis with intravenous albumin infusion in cirrhotic patients with tense ascites. Br. Med. J., 30-4, 1655-1658.
12. Ferrai, H., Bjamasion, H., Wegryn, S.A. et al. (1993) Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology, 189, 795-801.
13. Ferraretti, A.P., Gianaroli, L., Diotallevi, L. et al. (1992) Doparnine treatment for severe ovarian hyperstimulation syndrome. Hum. Reprod., 7, 180-183.
14. Friedman, C.I., Schmidt, G. E., Chang, F. E. et al. (1984) Severe ovarian hyperstimulation following follicular aspiration. Am. J. Obstet. Gynecol., 150, 436-437.
15. Fukaya, T., Funayama, Y., Chiba, S. et al. (1994) Treatment of severe ovarian hyperstimulation syndrome by ultrafiltration and reinfusion of ascitic fluid. Fenil. Steril., 61, 561-564.
16. Gines, P., Arroyo, V., Vargas, V. et al. (1991) Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N. Engl. J. Med., 325, 829-835.
17. Grieg, P.D., Langer, B., Blendis, L.M. et al. (1980) Complications after peritoneovenous shunting for ascites. Am. J. Surg., 139, 125-131.
18. Jenkins, J.M., Mathur, R.S. and Cook, I.D. (1995) The management of severe ovarian hyperstimulation syndrome. Br. J. Obstet. Gynaecol, 102, 2-5.
19. Koike, T., Araki, S., Ogawa, S. et al. (1998) Clinical efficacy of a continuous autotransfusion system for the treatment of severe ovarian hyperstimulation syndrome. Hum. Reprod., 13, [Abstr.], 150.
20. Landini, S., Coli, U., Fracasso, A. et al. (1985) Spontaneous ascites filtration and reinfusion (SAFR) in cirrhotic patients. Int. J. Artif. Organs, 8, 277-280
21. Liebowitz, H.R. (1962) Hazards of abdominal paracentesis in the cirrhotic patient (part III). N. Y. State J. Med., 62, 2223-2229.
22. Manaka, C., Araki, S., Motoyama, M. et al. (1995) Management of ovarian hyperstimulation syndrome (in Japanese). Jpn J. Fertil. Steril., 40,427-132.
23. Navot, D., Bergh, P.A. and Laufer, N. (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril., 58, 249-261.
24. Nelson, W.P., Rosenbaum, J.D. and Strauss, M.D. (1951) Hyponatremia in hepatic cirrhosis following paracentesis. J. Clin. Invest., 30, 738-744.
25. Ochs, A., Rossle M., Haag, K. et al. (1995) The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N. Engl. J. Med., 332, 1192-1197.
26. Orvieto, R. and Ben-Rafael, Z. (1998) Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome. Hum. Reprod., 13, 3306-3309.
27. Parbhoo, S.P., Ajdukiewicz A. and Sherlock, S. (1974) Treatment of ascites by continuous ultraflltration and reinfusion of protein concentrate. Lancet, i, 949-952.
28. Pride, S.M., James, C. St J. and Yuen, B.H. (1990) The ovarian hyperstimulation syndrome. Semin. Reprod. Eiuiocrinol., 8, 247-260.
29. Revel, A., Barak, V., Lavy, Y. el al. (1996) Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertil. Steril., 66, 66-71.
30. Salerno, F., Badalamenti, S., Incerti, P.L. et al. (1987) Repeated paracentesis and iv albumin infusion to treat tense ascites in cirrhotic patients. A safe alternative therapy. J. Hepatol., 5, 102-108.
31. Satagostino, E., Mannucci, P.M., Gringeri, A. et al. (1994) Eliminating parvovirus B19 from blood products. Lancet, 343, 798.
32. Sayama, M., Araki, S., Motoyama, M. et al. (1996) The clinical efficacy of gamete intrafallopian transfer by minilaparotomy versus m vitro fertilization and embryo transfer. J. Obstet. Gynecol. Res., 22, 409-416.
33. Splendiani, G., Mazzarella, V., Tozzo. C. et al. (1994) Autologous protein reinfusion in severe ovary hyperstimulation syndrome. J. Am. Coll. Surg., 179, 25-28.
34. Stein, S.F., Fulenwinder, J.T. and Ansley, J.D. (1978) Accelerated fibrinogen and platelet destruction after peritoneovenous shunting. Gastroenterology, 74, 1161-1164.
35. Thaler, I., Yoffe, N., Kaftory, J.K. et al. (1981) Treatment of ovarian hyperstimulation syndrome: the physiologic basis for a modified approach. Fertil. Steril., 36, 110-113.
36. Yee, T.T., Cohen, B.J., Pasi, K.J. et al. (1996) Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate. Br. J. Hematol., 93, 457-159.